Charlestown, RI, United States of America

Kenneth P Raiche

This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenneth P Raiche. Retrieved from https://idiyas.com/inventor/kenneth-p-raiche

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kenneth P. Raiche: Innovator in Anticancer Agents

Introduction

Kenneth P. Raiche is a notable inventor based in Charlestown, Rhode Island. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anticancer agents. His work has been recognized for its potential impact on cancer treatment.

Latest Patents

Kenneth P. Raiche holds a patent for "Biaryl compounds useful as anticancer agents." This patent highlights his innovative approach to creating compounds that may play a crucial role in combating cancer.

Career Highlights

Raiche is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His role at Pfizer allows him to work on cutting-edge research and development in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Steven Wayne Goldstein and Kelly P. Longo. Their collaboration contributes to the innovative environment at Pfizer, fostering advancements in drug development.

Conclusion

Kenneth P. Raiche's work in developing anticancer agents exemplifies the importance of innovation in the pharmaceutical industry. His contributions are paving the way for new treatments that could benefit countless patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…